CNBC: As GLP-1 use hits new highs, employers weigh costs of covering the drugs
Key points
- GLP-1 use has reached new highs
- More employers are weighing the cost of covering these drugs
- New research examines possible effects on jobs, hiring and sick leave
CNBC reports that as GLP-1 use reaches new highs, more employers are weighing whether the benefits of covering these medications justify their high costs. New research examines how the drugs could affect jobs, hiring and sick leave.
Original report: CNBC ↗Edited with AI assistance. Facts are based on official sources and original reports. For information only; not legal, immigration or insurance advice.